Single User License
INR 161375
Site License
INR 322750
Corporate User License
INR 484125

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Venous Thromboembolism Global Clinical Trials Review, H1, 2015

Venous Thromboembolism Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2625CTIDB
  • |
  • Pages: 107
  • |
  • April 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Venous Thromboembolism Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Venous Thromboembolism Global Clinical Trials Review, H1, 2015" provides data on the Venous Thromboembolism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Venous Thromboembolism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Venous Thromboembolism. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Venous Thromboembolism 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Venous Thromboembolism to Cardiovascular Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Venous Thromboembolism to Cardiovascular Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Venous Thromboembolism 25

Subjects Recruited Over a Period of Time 29

Clinical Trials by Sponsor Type 30

Prominent Sponsors 31

Top Companies Participating in Venous Thromboembolism Therapeutics Clinical Trials 32

Prominent Drugs 33

Clinical Trial Profiles 34

Clinical Trial Overview of Top Companies 34

C. H. Boehringer Sohn AG & Co. KG 34

Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 34

Bayer AG 39

Clinical Trial Overview of Bayer AG 39

GlaxoSmithKline plc 42

Clinical Trial Overview of GlaxoSmithKline plc 42

Sanofi 44

Clinical Trial Overview of Sanofi 44

Astellas Pharma Inc. 46

Clinical Trial Overview of Astellas Pharma Inc. 46

Pfizer Inc. 48

Clinical Trial Overview of Pfizer Inc. 48

Bristol-Myers Squibb Company 50

Clinical Trial Overview of Bristol-Myers Squibb Company 50

Daiichi Sankyo Company, Limited 52

Clinical Trial Overview of Daiichi Sankyo Company, Limited 52

AstraZeneca PLC 54

Clinical Trial Overview of AstraZeneca PLC 54

Johnson & Johnson 56

Clinical Trial Overview of Johnson & Johnson 56

Clinical Trial Overview of Top Institutes / Government 57

McMaster University 57

Clinical Trial Overview of McMaster University 57

Hamilton Health Sciences 58

Clinical Trial Overview of Hamilton Health Sciences 58

Ottawa Hospital Research Institute 59

Clinical Trial Overview of Ottawa Hospital Research Institute 59

The Utrecht Institute for Pharmaceutical Sciences 60

Clinical Trial Overview of The Utrecht Institute for Pharmaceutical Sciences 60

Universita degli Studi dell'Insubria 61

Clinical Trial Overview of Universita degli Studi dell'Insubria 61

Capital District Health Authority, Canada 62

Clinical Trial Overview of Capital District Health Authority, Canada 62

Centre Hospitalier Universitaire de Grenoble 63

Clinical Trial Overview of Centre Hospitalier Universitaire de Grenoble 63

Hadassah Medical Organization 64

Clinical Trial Overview of Hadassah Medical Organization 64

Juntendo University School of Medicine 65

Clinical Trial Overview of Juntendo University School of Medicine 65

Leiden University Medical Center 66

Clinical Trial Overview of Leiden University Medical Center 66

Five Key Clinical Profiles 67

Appendix 105

Abbreviations 105

Definitions 105

Research Methodology 106

Secondary Research 106

About GlobalData 107

Contact Us 107

Disclaimer 107

Source 107

List of Figures

Venous Thromboembolism Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Venous Thromboembolism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Venous Thromboembolism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Venous Thromboembolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Venous Thromboembolism Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Venous Thromboembolism Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Venous Thromboembolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Venous Thromboembolism Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Venous Thromboembolism to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15

Venous Thromboembolism Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Venous Thromboembolism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Venous Thromboembolism to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18

Venous Thromboembolism Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Venous Thromboembolism Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Venous Thromboembolism Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Venous Thromboembolism Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Venous Thromboembolism Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Venous Thromboembolism Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Venous Thromboembolism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29

Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30

Venous Thromboembolism Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31

Venous Thromboembolism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32

Venous Thromboembolism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

GlobalData Methodology 106

List of Tables

Venous Thromboembolism Therapeutics, Global, Clinical Trials by Region, 2015* 7

Venous Thromboembolism Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Venous Thromboembolism Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Venous Thromboembolism Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Venous Thromboembolism Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Venous Thromboembolism Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Venous Thromboembolism Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Venous Thromboembolism Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Venous Thromboembolism to Cardiovascular Clinical Trials, G7 Countries (%), 2015* 15

Venous Thromboembolism Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Venous Thromboembolism Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Venous Thromboembolism to Cardiovascular Clinical Trials, E7 Countries (%), 2015* 18

Venous Thromboembolism Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Venous Thromboembolism Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Venous Thromboembolism Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Venous Thromboembolism Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Venous Thromboembolism Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Venous Thromboembolism Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Venous Thromboembolism Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Venous Thromboembolism Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Venous Thromboembolism Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Venous Thromboembolism Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29

Venous Thromboembolism Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30

Venous Thromboembolism Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31

Venous Thromboembolism Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32

Venous Thromboembolism Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015* 34

Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 39

Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 42

Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 44

Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 46

Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 48

Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 50

Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015* 52

Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 54

Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 56

Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2015* 57

Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2015* 58

Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2015* 59

Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by The Utrecht Institute for Pharmaceutical Sciences, 2015* 60

Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Universita degli Studi dell'Insubria, 2015* 61

Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital District Health Authority, Canada, 2015* 62

Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Grenoble, 2015* 63

Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2015* 64

Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University School of Medicine, 2015* 65

Venous Thromboembolism Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015* 66

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Venous Thromboembolism Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Venous Thromboembolism, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com